AI helps to fight against antibiotic-resistant superbugs
Scientists aim to support the development of vaccines and antibiotics for infections increasingly resistant to existing drugs.
UK scientists are launching a three-year initiative to use AI in the fight against drug-resistant infections, a growing threat to public health.
The project, backed by £45 million from GSK and coordinated with the Fleming Initiative, aims to develop new tools against pathogens that currently evade treatment.
Researchers will focus on priority bacteria and fungi identified by the World Health Organisation, including E. coli, Klebsiella pneumoniae, MRSA and Aspergillus.
These AI models will be utilised to design antibiotics and enhance the understanding of immune responses, with data shared globally to expedite drug development.
Experts warn that antimicrobial resistance could claim millions of lives by 2050 if new solutions are not found. The initiative reflects an urgent need to pool scientific expertise and technology to create next-generation treatments and vaccines for resistant infections.
Would you like to learn more about AI, tech, and digital diplomacy? If so, ask our Diplo chatbot!
